What is one significant benefit of using MAT for individuals with opioid use disorder?

Using Medication-Assisted Treatment (MAT) for individuals with opioid use disorder offers significant benefits, particularly in improving social functioning and reducing the risk of overdose. MAT combines medications, such as buprenorphine or methadone, with therapeutic support to help patients manage their addiction more effectively.

The medications in MAT work by reducing cravings and withdrawal symptoms, which allows individuals to regain control over their lives. As a result, many individuals can hold jobs, maintain relationships, and engage in positive social activities that may have been challenging before treatment. Moreover, by stabilizing individuals and preventing relapse, MAT significantly lowers the chances of experiencing an overdose, which is a critical concern in opioid use disorders where the risk of overdose is heightened due to fluctuations in tolerance.

In contrast, increased frequency of illicit drug use, higher risk of overdose, and the idea that MAT eliminates the need for professional support are not benefits associated with a successful MAT program. Instead, MAT is designed to support recovery through ongoing care and professional guidance.